Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Odds Ratio01:09

Odds Ratio

2.0K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Hazard Ratio01:12

Hazard Ratio

662
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
662
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

674
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
674
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

4.0K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterising end-of-life decision-making of life-sustaining treatment among Japanese nurses.

International journal of palliative nursing·2021
Same author

A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study.

International journal of chronic obstructive pulmonary disease·2017
Same author

Comparative effect of fixed-dose combination tablets of candesartan cilexetil/amlodipine versus olmesartan medoxomil/azelnidipine on laboratory parameters in patients with hypertension: a retrospective cohort study.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2015
Same author

Ghrelin and leptin modulate immunity and liver function in overweight children.

Pediatrics international : official journal of the Japan Pediatric Society·2009

Related Experiment Video

Updated: Mar 2, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Method to estimate relative risk using exposed proportion and case group data.

Yoichi Yada1

  • 1Division of Pharmacology, Department of Biomedical Sciences, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi City, Tokyo, 173-8610, Japan. yada67yoichi@gmail.com.

Scientific Reports
|May 20, 2017
PubMed
Summary

This study introduces a new equation to estimate relative risk using only case group data and the exposed proportion. This method avoids the need for control or follow-up groups, saving time and resources in risk assessment.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Related Experiment Videos

Last Updated: Mar 2, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Medical Research

Background:

  • Relative risk estimation is crucial in many research fields for understanding factor-event relationships.
  • Traditional relative risk calculation requires data from two follow-up groups, which is often costly and time-consuming.
  • Estimating relative risk directly from case group data without approximation is mathematically challenging.

Purpose of the Study:

  • To mathematically clarify the obstacle in estimating relative risk using case-control data.
  • To propose a novel equation for estimating relative risk using only the exposed proportion and case group data.
  • To provide a method for calculating the confidence interval for the proposed relative risk estimator.

Main Methods:

  • Mathematical derivation of a new equation for relative risk estimation.
  • The equation is derived independently of Bayesian methods.
  • Development of a confidence interval estimation method for the new relative risk estimator.

Main Results:

  • A new, non-Bayesian equation enables relative risk estimation without control or follow-up groups.
  • The proposed method utilizes readily available case group data and exposed proportion.
  • Demonstrated utility through both theoretical and real-world examples.

Conclusions:

  • The developed equation offers a more efficient and less resource-intensive approach to relative risk estimation.
  • This method simplifies risk assessment in epidemiological and clinical research.
  • The findings facilitate more accessible and timely risk analysis in various scientific domains.